Renan de Jesus Teixeira

6PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer cell biologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 25, 2026
A baseline systemic inflammatory signature predicts anti-PD-1 response in advanced melanoma.

|Nov 05, 2025
Exploring blood cell biomarkers in melanoma patients receiving adjuvant anti-PD-1 immunotherapy.

Renan de Jesus Teixeira, Bruna Pereira Sorroche, Vinicius Gonçalves de Souza

|Aug 13, 2025
Perspectives on smoking cessation in the oncology environment: insights from brazilian patients and healthcare providers.

Raquel Descie Veraldi Leite, Ricardo Ribeiro Gama, Fabiana de Lima Vazquez

|May 03, 2025
CD24, NFIL3, FN1, and KLRK1 signature predicts melanoma immunotherapy response and survival.

Bruna Pereira Sorroche, Renan de Jesus Teixeira, Vinicius Gonçalves de Souza

|Dec 14, 2023
Unveiling the role of MGMT and DAPK hypermethylation in response to anti-EGFR agents: Molecular insights for advancing HNSCC treatment.

Lidia Maria Rebolho Batista Arantes, Renato José Silva-Oliveira, Ana Carolina de Carvalho

|Jul 31, 2023
miR-99a-5p as a biomarker for lymph node metastasis prediction in oral squamous cell carcinoma patients.

Cristiane Pereira Vargas Cousseau, Bruna Pereira Sorroche, Renan de Jesus Teixeira

Pageof 1